336 related articles for article (PubMed ID: 28514753)
1. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
3. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
4. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
[TBL] [Abstract][Full Text] [Related]
5. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
6. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
7. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
8. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
9. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
[TBL] [Abstract][Full Text] [Related]
11. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
12. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
13. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
14. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
[TBL] [Abstract][Full Text] [Related]
15. Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.
Tseng CH; Chang CY; Mo LR; Lin JT; Tai CM; Perng DS; Lin CW; Hsu YC
Ann Hepatol; 2018 Aug; 17(5):789-794. PubMed ID: 30145564
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
19. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
20. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).
Teshale E; Lu M; Rupp LB; Holmberg SD; Moorman AC; Spradling P; Vijayadeva V; Boscarino JA; Schmidt MA; Gordon SC;
J Viral Hepat; 2014 Dec; 21(12):917-20. PubMed ID: 25131445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]